Administering medications through the nose as an alternative to injections or IVs is becoming increasingly popular in emergency departments and ambulances, according to a paper by Loyola Medicine ...
In an IND-enabling study, intranasal COVI-AMG nAb (STI-2099 or COVI-DROPSTM) very early on decreased COVID-19 disease severity and shortened the duration of the disease in infected hamsters, and ...
A recent study published in Pathogens reported that an intranasal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine induced mucosal immune responses in mice. Study: Intranasal ...
The FDA approved a new, over-the-counter intranasal naloxone spray for the treatment of emergency opioid overdose. HealthDay News — The U.S. Food and Drug Administration has approved another ...
The enduring waves of SARS-CoV-2 breakthrough infections create a global impediment that requires additional measures beyond vaccination to mitigate this perpetual situation. SARS-CoV-2 is an RNA ...
Mouse and human data hint that biological differences may shape drug bioavailability in ways clinical trials often overlook ...
Researchers have shown in mice models of Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies, that the intranasal administration of rifampicin and resveratrol in combination is ...
For decades, influenza vaccines have been judged largely by the antibodies they generate in the bloodstream, a measure that ...
Recent advances in drug delivery have led to significant innovations including polymer implants, transdermal patches, and sophisticated oral controlled-release formulations. These technologies, ...
The small teleost zebrafish (Danio rerio) has become a critically important laboratory animal in biomedicine. One of their key practical advantages, the convenient method of small-molecule ...
New performance and characterization study in collaboration with leading European medical center marks a critical milestone in the validation of the NASARIX™ allergy blocker’s protective barrier ...
The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results